$59.99
1.99[3.43%]
At close: Apr 17
$59.99
0[0.00%]
After Hours: 4:05PM EDT
Keros Therapeutics
(NASDAQ:KROS)Keros Therapeutics Stock (NASDAQ:KROS), Quotes and News Summary
Keros Therapeutics Stock (NASDAQ: KROS) stock price, news, charts, stock research, profile.
| Open | $58.560 |
| Close | $59.270 |
| Volume / Avg. | 397.880K / 376.733K |
| Day Range | 56.530 - 59.495 |
| 52 Wk Range | 27.020 - 73.000 |
| Market Cap | $2.159B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 44 |
| Short Interest | 8.41% |
| Days to Cover | 6.27 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Keros Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, devel...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Keros Therapeutics (KROS) stock?
You can purchase shares of Keros Therapeutics (NASDAQ: KROS) through any online brokerage.
Who are Keros Therapeutics's (KROS) competitors?
Other companies in Keros Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN) and PTC Therapeutics (NASDAQ:PTCT).
What is the target price for Keros Therapeutics (KROS) stock?
The latest price target for Keros Therapeutics (NASDAQ: KROS) was reported by Piper Sandler on Wednesday, March 27, 2024. The analyst firm set a price target for 105.00 expecting KROS to rise to within 12 months (a possible 75.03% upside). 14 analyst firms have reported ratings in the last year.
Current Stock Price for Keros Therapeutics (KROS)?
The stock price for Keros Therapeutics (NASDAQ: KROS) is $59.99 last updated April 17, 2024 at 4:05 PM EDT.
Does Keros Therapeutics (KROS) pay a dividend?
There are no upcoming dividends for Keros Therapeutics.
When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?
Keros Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.
Is Keros Therapeutics (KROS) going to split?
There is no upcoming split for Keros Therapeutics.
What sector and industry does Keros Therapeutics (KROS) operate in?
Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.